{"transactions":[{"id":961746,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71073,"kind":"person","name":"Johnson Shane Aaron","position":1,"cik":"0001889332","reported_name":"Johnson Shane Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & General Manager"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-19T16:42:54.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/19/2025 and will vest in equal installments monthly, in arrears, over 36 months (1/36 per month)"}],"balance_after":12400,"derivative":{"exercise_price":1.29,"expiration_date":"2030-12-18","underlying":"Common shares","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001213900-25-123639","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390025123639/ownership.xml","form_type":"4"}},{"id":1322544,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71073,"kind":"person","name":"Johnson Shane Aaron","position":1,"cik":"0001889332","reported_name":"Johnson Shane Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & General Manager"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-23T14:28:12.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/20/2024 and will vest in equal installments monthly over 36 months (1/36 per month)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split."}],"balance_after":3900,"derivative":{"exercise_price":4.14,"expiration_date":"2029-12-19","underlying":"Common shares","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001213900-24-111570","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390024111570/ownership.xml","form_type":"4"}},{"id":1699949,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71073,"kind":"person","name":"Johnson Shane Aaron","position":1,"cik":"0001889332","reported_name":"Johnson Shane Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & General Manager"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-26T18:09:48.000Z","date":"2023-12-23","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month)."}],"balance_after":48000,"derivative":{"exercise_price":0.37,"expiration_date":"2028-12-22","underlying":"Common shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-23-098497","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390023098497/ownership.xml","form_type":"4"}},{"id":2081013,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71073,"kind":"person","name":"Johnson Shane Aaron","position":1,"cik":"0001889332","reported_name":"Johnson Shane Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & General Manager"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-12-19T21:59:53.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/16/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."}],"balance_after":8000,"derivative":{"exercise_price":1.78,"expiration_date":"2027-12-15","underlying":"Common shares","underlying_shares":4200},"source":{"system":"sec-edgar","filing":"0001213900-22-080992","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022080992/ownership.xml","form_type":"4"}},{"id":2109887,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71073,"kind":"person","name":"Johnson Shane Aaron","position":1,"cik":"0001889332","reported_name":"Johnson Shane Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP & General Manager"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-11-19T00:36:17.000Z","date":"2022-11-14","kind":"disposition_to_issuer","acquired":false,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 4,200 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 3,800 derivative securities of the Issuer."},{"field":"shares","element":"transactionShares","label":"F3","text":"On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 4,200 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 3,800 derivative securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the Issuer's common stock was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 4,200 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 3,800 derivative securities of the Issuer."}],"balance_after":3800,"derivative":{"exercise_price":2.78,"expiration_date":"2027-11-13","underlying":"Common shares","underlying_shares":4200},"source":{"system":"sec-edgar","filing":"0001213900-22-073946","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022073946/ownership.xml","form_type":"4/A","original_submission_date":"2022-11-15"}},{"id":2115762,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71073,"kind":"person","name":"Johnson Shane Aaron","position":1,"cik":"0001889332","reported_name":"Johnson Shane Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & General Manager"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-11-16T00:52:29.000Z","date":"2022-11-14","kind":"grant","acquired":true,"shares":4200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."}],"balance_after":8000,"derivative":{"exercise_price":2.78,"expiration_date":"2027-11-13","underlying":"Common shares","underlying_shares":4200},"source":{"system":"sec-edgar","filing":"0001213900-22-072924","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022072924/ownership.xml","form_type":"4"}},{"id":2440977,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71073,"kind":"person","name":"Johnson Shane Aaron","position":1,"cik":"0001889332","reported_name":"Johnson Shane Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GM of BayMedica LLC"}}],"security":"Common Stock","published_at":"2022-01-06T23:40:01.000Z","date":"2022-01-06","kind":"purchase","acquired":true,"shares":8500,"price":1.26,"value":10710.0,"ownership":{"direct":true},"balance_after":304595,"source":{"system":"sec-edgar","filing":"0001213900-22-001005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390022001005/ownership.xml","form_type":"4"}},{"id":2455944,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71073,"kind":"person","name":"Johnson Shane Aaron","position":1,"cik":"0001889332","reported_name":"Johnson Shane Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GM of BayMedica LLC"}}],"security":"Common Stock","published_at":"2021-12-31T00:22:58.000Z","date":"2021-12-30","kind":"purchase","acquired":true,"shares":8093,"price":1.3266,"value":10736.1738,"ownership":{"direct":true},"balance_after":296095,"source":{"system":"sec-edgar","filing":"0001213900-21-068212","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390021068212/ownership.xml","form_type":"4"}},{"id":2512196,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71073,"kind":"person","name":"Johnson Shane Aaron","position":1,"cik":"0001889332","reported_name":"Johnson Shane Aaron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GM of BayMedica LLC"}}],"security":"Common Stock","published_at":"2021-11-15T20:33:59.000Z","date":"2021-11-15","kind":"purchase","acquired":true,"shares":5000,"price":1.369,"value":6845.0,"ownership":{"direct":true},"balance_after":288002,"source":{"system":"sec-edgar","filing":"0001213900-21-059271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1728328/000121390021059271/ownership.xml","form_type":"4"}}]}